NFNikolay S. Frolov

Nikolay S. Frolov

*This is an algorithmically generated author record based on publicly available information.

Nikolay S. Frolov has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The effect of succinate containing crystalloid solution on the inflammatory response in intensive care of community-acquired pneumonia in children: a prospective open comparative study

    by Владимир Викторович Лазарев, P. E. Anchutin, M. V. Bykov, D. A. Smirnov, T. A. Pchelicnceva, N. S. Frolov, H. M. Makhachilaeva, B. I. Golubev

    INTRODUCTION: The severe course of community-acquired pneumonia (CAP) is associated with an excessive inflammatory response. The use of a succinate-containing crystalloid solution (SCCS) as part of the treatment regimen for CAP helps to reduce the inflammatory response. OBJECTIVES: Assessment of the dynamics of markers of the inflammatory process during complex intensive therapy with infusion of a succinate-containing drug in children with community-acquired pneumonia. MATERIALS AND METHODS: The study identified 2 groups of children. The main group of use of SCCS — 24 children. The control group consisted of 76 children. In the main group, 2 subgroups were identified depending on the rate of administration of SCCS: 5 and 2.5 ml/kg/hour. The sample size was determined based on the intermediate results of statistical analysis until statistically significant differences were obtained RESULTS: In the group of use of SCCS, it was noted: a reduction in the duration of stay in intensive care and a decrease in the need for oxygen therapy by an average of 2 days, normalization of indicators on the pSOFA (pediatric Sequential Organ Failure Assessment score) scale by 2 days faster, lower leukocyte levels on the 2nd–4th day, a decrease in neutrophils on the 3rd and 4th days, a decrease in-reactive protein (CRP) by the 3rd day. Reduction of proinflammatory cytokines (IL-6, tumor necrosis factor-α [TNF-α]) by 3 days in children of the 5 ml/kg/hour subgroup. A direct correlation was established between IL-6 and the profi scale and an inverse relationship between the proportion of TFR in total intravenous infusion and the level of lactatedehydrogenase on day 3. All differences are statistically significant. CONCLUSIONS: SCCS contributes to the effective suppression of the inflammatory response in children with CAP. The intravenous infusion regimen of 5.0 ml/kg/hour has a more pronounced effect in reducing the level of inflammatory markers.

  • Open Access

    Effect of Succinate Crystalloid Solution on Hemostasis in Children with Severe Community-acquired Pneumonia

    by Vladimir V. Lazarev, Pavel E. Anchutin, Manuel M. Megeryan, Mikhail V. Bykov, Dmitry A. Smirnov, Tatiana A. Pchelicnceva, Nikolay S. Frolov, Khurzada M. Makhachilaeva, Boris I. Golubev, Elena A. Spiridonova

    Aim of the study. To improve outcomes in children with severe community-acquired pneumonia (CAP) by including succinate-containing crystalloid solution (SCCS) in the treatment plan.Materials and methods. The study included 100 patients diagnosed with CAP. SCCS was administered to 24 patients from the prospective (main) group, divided into 2 equal subgroups of 12 subjects who received SCCS with the infusion rate of 2.5 ml/kg/h (subgroup 1) and 5.0 ml/kg/h (subgroup 2). Treatment of 76 patients in the retrospective (control) group did not include SCCS.Results. Greater decreases in D-dimer (by 418.5 ng/mL vs. 137.0 ng/mL, P=0.026) by day 3 and in fibrinogen (by 1.7 g/L vs. 0.2 g/L, P0.001) by day 3 and (3.8 g/L vs. 0.5 g/L, P=0.002) by day 5 of hospitalization were found in children from the main group vs. the control group. Fibrinogen levels decreased in both study subgroups, although subgroup 1 had significantly higher fibrinogen levels on day 2 of ICU stay (P=0.034). A significant increase in activated partial thromboplastin time (aPTT) of 9.7 seconds was observed on day 3 in the main group versus 2.9 seconds in the control group (P0.001). There was a direct correlation between fibrinogen level and neutrophil count on day 2 of ICU stay (R=0.479, P=0.033). Conclusion. The use of SCCS in the treatment of severe CAP helps to prevent thrombotic complications, reduces hypoxia-induced changes in the coagulation system, and enhances the effects of unfractionated heparin. SCCS infusion at a rate of 5.0 mL/kg/h effectively reduces the levels of hypercoagulation markers, while its administration at a rate of 2.5 ml/kg/h potentiates the effects of unfractionated heparin. The effects of SCCS on hemostasis in severe CAP are equivalent to those of a moderate anticoagulant.


  • Elimination of Intestinal Hypoxia in Complex Treatment of Intestinal Failure (Case Report)

    by Mikhail V. Bykov, Vladimir V. Lazarev, Aleksey D. Mayorov, Mariya S. Tsesareva, Vyacheslav S. Nafikov, Anna S. Koroleva, Valentin V. Sytkov, Dmitriy A. Severinov, Nikolay S. Frolov, Dmitriy V. Chernyshev, et al.

    INTRODUCTION: Currently, various approaches to the treatment of intestinal failure (IF) are considered. In search for pathogenetically justified therapy, it is possible to use oxygenated saline enteral solution (OSES). АIM: To demonstrate, by gas analysis of the introduced oxygenated saline enteral solution and the excreted intestinal fluid, the possibility of gas exchange in the intestine with increased oxygen extraction under hypoxic conditions. An 8-year-old child with burdened premorbid history and severe community–acquired bilateral pleuropneumonia kept on mechanical ventilation, had signs of IF (disorder in passage, absence of independent defecation for more than two days). During treatment and observation of the child, enteral feeding was attempted with pharmacological stimulation with prokinetics, and introduction of laxative sorbent with prebiotic effect (lactulose). Because of non-effectiveness of these measures, it was decided to perform intestinal lavage with OSES introduced through the nasogastral tube. In 30 minites after start of OSES introduction, the gastrointestinal tract motility notably enhanced, in 1.5 hour from the beginning of the procedure, fractional passage of a significant amount of thick fecal masses was noted, after which intestinate — liquid stool stained yellow with bile, was obtained. During the procedure, a comparative analysis of the gas composition of the introduced OSES and excreted intestinate was done. In the excreted solution, 97-fold decrease of рО2 from 659 to 6.8 mm Hg, and 3.6-fold increase in CO2 tension from 23 to 85.7 mm Hg, were noted. CONCLUSION: Oxygenation of the enteral environment by barbotage of a saline enteral solution introduced through a tube is an effective component of intensive therapy for intestinal failure syndrome, taking into account the ability of the gastrointestinal tract tissues to actively participate in gas exchange: extract oxygen and release carbon dioxide.

  • Open Access

    Sialorrhea in the assessment and correction of water balance in a 2 month old baby in the ICU: a case report

    by Владимир Викторович Лазарев, M. M. Megeryan, D. A. Smirnov, M. V. Bykov, N. S. Frolov

    INTRODUCTION: In some cases, saliva production (sialorrhea — hypersalivation) can be so significant that it needs to be monitored and accounted for in the assessment and maintenance of the patient's water balance. OBJECTIVE: Description of a clinical case of sialorrhea, which had a clinically significant manifestation in the assessment and maintenance of water balance in a 2-month-old child in the intensive care unit (ICU). MATERIALS AND METHODS: Baby, 2 month old, was treated in the ICU with a diagnosis: perinatal organic hypoxic-ischemic lesion of the central nervous system of a newborn, congenital pathology of the brain, respiratory failure III stage, convulsions of the newborn, neonatal coma. In the complex of specific therapy, he received enteral feeding, correction of water and nutritional status. RESULTS: On the first day of detection of sialorrhea, the level of salivation of 2.81 ml/kg/hour (the norm is 1.3 ml/kg/hour) exceeded the physiological values by more than 2 times. The excess of normal values of salivation persisted for the next two days, as well as on the 9th day of its control, which required taking into account the amount of fluid lost with saliva in the calculation of its daily requirement. No specific measures were required in the treatment of the patient to eliminate sialorrhea; within 14 days from the moment the fact of sialorrhea was established, the level of salivation returned to normal values. CONCLUSIONS: In assessing the cumulative factors that cause fluid loss in ICU patients, especially infants, it is also necessary to take into account the presence and intensity of salivation, which can manifest as sialorrhea, when calculating the volume and administration of infusion drugs.